Literature DB >> 17519490

Treatment options for patients with severe gastroparesis.

Hasse Abrahamsson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519490      PMCID: PMC1954884          DOI: 10.1136/gut.2005.078121

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  57 in total

Review 1.  Gastric emptying in diabetes: an overview.

Authors:  M Horowitz; J M Wishart; K L Jones; G S Hebbard
Journal:  Diabet Med       Date:  1996-09       Impact factor: 4.359

2.  The current role of erythromycin in the clinical management of gastric emptying disorders.

Authors:  M Camilleri
Journal:  Am J Gastroenterol       Date:  1993-02       Impact factor: 10.864

3.  Effect of tegaserod on gut transit in male and female subjects.

Authors:  L Degen; C Petrig; D Studer; S Schroller; C Beglinger
Journal:  Neurogastroenterol Motil       Date:  2005-12       Impact factor: 3.598

4.  Assessment of gastric emptying using a low fat meal: establishment of international control values.

Authors:  G Tougas; E Y Eaker; T L Abell; H Abrahamsson; M Boivin; J Chen; M P Hocking; E M Quigley; K L Koch; A Z Tokayer; V Stanghellini; Y Chen; J D Huizinga; J Rydén; I Bourgeois; R W McCallum
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

5.  Hyperglycemia attenuates erythromycin-induced acceleration of liquid-phase gastric emptying of hypertonic liquids in healthy subjects.

Authors:  Ioannis E Petrakis; Nektarios Kogerakis; George Prokopakis; George Zacharioudakis; Sokrates Antonakakis; Nikolaos Vrachassotakis; George Chalkiadakis
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

6.  Hyperglycemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in healthy subjects.

Authors:  I E Petrakis; N Kogerakis; N Vrachassotakis; I Stiakakis; G Zacharioudakis; G Chalkiadakis
Journal:  Abdom Imaging       Date:  2002 May-Jun

7.  Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

Authors:  I Soykan; B Sivri; I Sarosiek; B Kiernan; R W McCallum
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

8.  Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation.

Authors:  Zhiyue Lin; Jameson Forster; Irene Sarosiek; Richard W McCallum
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

9.  An energy algorithm improves symptoms in some patients with gastroparesis and treated with gastric electrical stimulation.

Authors:  N Abidi; W L Starkebaum; T L Abell
Journal:  Neurogastroenterol Motil       Date:  2006-04       Impact factor: 3.598

10.  Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis.

Authors:  C Mansi; V Savarino; S Vigneri; D Perilli; P Melga; L Sciabà; D De Martini; G S Mela
Journal:  Am J Gastroenterol       Date:  1995-11       Impact factor: 10.864

View more
  18 in total

Review 1.  Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies.

Authors:  Bing Pang; Qiang Zhou; Jun-Ling Li; Lin-Hua Zhao; Xiao-Lin Tong
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

2.  Diabetic Gastroparesis: A Review.

Authors:  Clipper F Young; Marianne Moussa; Jay H Shubrook
Journal:  Diabetes Spectr       Date:  2020-08

Review 3.  Small Bowel Dysmotility, Pseudoobstruction, and Functional Correlation with Histopathology: Lessons Learned.

Authors:  Zorisadday Gonzalez; Richard McCallum
Journal:  Curr Gastroenterol Rep       Date:  2020-02-20

4.  Temporary gastric neuromodulation for intractable nausea and vomiting.

Authors:  S Ullah; R Arsalani-Zadeh; P Sedman; G Avery; G S Duthie; J MacFie
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

5.  Postprandial plasma glucose response and gastrointestinal symptom severity in patients with diabetic gastroparesis.

Authors:  Eva A Olausson; Håkan Grundin; Mats Isaksson; Christina Brock; Asbjørn M Drewes; Stig Attvall; Magnus Simrén
Journal:  J Diabetes Sci Technol       Date:  2014-05-06

6.  High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis.

Authors:  Gregory O'Grady; John U Egbuji; Peng Du; Leo K Cheng; Andrew J Pullan; John A Windsor
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

Review 7.  Treatment of gastrointestinal autonomic neuropathy.

Authors:  Hans Törnblom
Journal:  Diabetologia       Date:  2015-12-03       Impact factor: 10.122

8.  The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.

Authors:  John Broad; Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 9.  Treating nausea and vomiting in palliative care: a review.

Authors:  Paul Glare; Jeanna Miller; Tanya Nikolova; Roma Tickoo
Journal:  Clin Interv Aging       Date:  2011-09-12       Impact factor: 4.458

10.  Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor.

Authors:  Chunlin Chen; Wenwen Zhang; Muhammad Bari; Cristina Almansa; Mike Baratta; Maria Rosario
Journal:  Clin Pharmacol       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.